- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 0WD: [[(2R,3S,4R,5R)-5-(3-aminocarbonyl-4H-pyridin-1-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methyl hydrogen phosphate(Non-covalent)
- 4 x 0WE: N-methyl-N-[(3-methyl-1-benzofuran-2-yl)methyl]-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)propanamide(Non-covalent)
0WE.2: 15 residues within 4Å:- Chain A: F.96, A.97, M.99, L.102, Y.147, Q.155, N.156, Y.157, M.160, S.197, K.199, V.201, F.204, I.207
- Ligands: 0WD.1
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:L.102, A:Y.147, A:N.156, A:V.201, A:V.201, A:F.204, A:I.207
- Hydrogen bonds: A:A.97, A:A.97
- Water bridges: A:M.99
- pi-Stacking: A:Y.157, A:Y.157
0WE.4: 15 residues within 4Å:- Chain B: F.96, A.97, M.99, L.102, Y.147, Q.155, N.156, Y.157, M.160, S.197, K.199, V.201, F.204, I.207
- Ligands: 0WD.3
13 PLIP interactions:13 interactions with chain B- Hydrophobic interactions: B:L.102, B:Y.147, B:N.156, B:V.201, B:V.201, B:F.204, B:I.207
- Hydrogen bonds: B:A.97, B:A.97, B:Y.157
- Water bridges: B:M.99
- pi-Stacking: B:Y.157, B:Y.157
0WE.6: 15 residues within 4Å:- Chain C: F.96, A.97, M.99, L.102, Y.147, Q.155, N.156, Y.157, M.160, S.197, K.199, V.201, F.204, I.207
- Ligands: 0WD.5
12 PLIP interactions:12 interactions with chain C- Hydrophobic interactions: C:L.102, C:Y.147, C:N.156, C:V.201, C:V.201, C:F.204, C:I.207
- Hydrogen bonds: C:A.97, C:A.97
- Water bridges: C:M.99
- pi-Stacking: C:Y.157, C:Y.157
0WE.8: 15 residues within 4Å:- Chain D: F.96, A.97, M.99, L.102, Y.147, Q.155, N.156, Y.157, M.160, S.197, K.199, V.201, F.204, I.207
- Ligands: 0WD.7
13 PLIP interactions:13 interactions with chain D- Hydrophobic interactions: D:L.102, D:Y.147, D:N.156, D:V.201, D:V.201, D:F.204, D:I.207
- Hydrogen bonds: D:A.97, D:A.97, D:Y.157
- Water bridges: D:M.99
- pi-Stacking: D:Y.157, D:Y.157
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kaplan, N. et al., Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor. Antimicrob.Agents Chemother. (2012)
- Release Date
- 2012-09-19
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 0WD: [[(2R,3S,4R,5R)-5-(3-aminocarbonyl-4H-pyridin-1-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methyl hydrogen phosphate(Non-covalent)
- 4 x 0WE: N-methyl-N-[(3-methyl-1-benzofuran-2-yl)methyl]-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)propanamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kaplan, N. et al., Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor. Antimicrob.Agents Chemother. (2012)
- Release Date
- 2012-09-19
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A